Products
Semaglutide TFA (Ozempic, GLP-1 receptor agonist)-Therapeutic peptides drug benchmark for in-vivo/in-vitro study
Cat No.: GMP-Bios-peptide-004 Product Name: Semaglutide TFA Structural formula:
Semaglutide TFA, the trifluoroacetic acid salt form of Semaglutide. Semaglutide acts like human glucagon-like peptide-1 (GLP-1) such that it increases insulin secretion, thereby increasing sugar metabolism. Semaglutide, sold under the brand name Ozempic among others, is an anti-diabetic medicationused for the treatment of type 2 diabetes and chronic weight management.
Order information
| Catalog No. | Package | Price(In USD) | Qty (Quantity) | Sum(In USD) |
|---|---|---|---|---|
| GMP-Bios-peptide-004-5mg | 5mg | 780 | ||
| GMP-Bios-peptide-004-25mg | 25mg | 1950 | ||
| GMP-Bios-peptide-004-50mg | 50mg | 2925 | GMP-Bios-peptide-004-100mg | 100mg | 3900 |
| GMP-Bios-peptide-004-500mg | 500mg | 7800 | ||
| GMP-Bios-peptide-004-xmg | ≥500mg | Inquiry | ||
| Shipping Cost: | 760.00 | |||
| Total: | ||||
Description
| Product Name | Semaglutide TFA |
| Brand name | Ozempic |
| CAS No. | 910463-68-2 |
| Formula | C189H292F3N45O61 |
| Biological Activity | Semaglutide acts like human glucagon-like peptide-1 (GLP-1) such that it increases insulin secretion. |
| Purity | Purity: ≥98% (HPLC) |
| Application | Therapeutic peptides drug benchmark or raw material for peptide drugs or peptide conjugation drugs discovery and development. |
| Predicted Molecular Mass | 4210.63 |
| Formulation & Reconstitution | Powder |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
<